While activating JAK3 mutations have so far been associated with lymphoid hyperplasia and leukemia (11), loss-of-function and hypomorphic mutations lead to a broader variety of clinical phenotypes ranging from lymphoproliferative disorders and milder/later onset of immunodeficiency to severe combined immunodeficiency (12, 13). The gene discussed is JAK3; the disease is immune system disorder.